Copyright Reports & Markets. All rights reserved.

Global Blood Plasma Derivatives Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Blood Plasma Derivatives

      • 1.1 Definition of Blood Plasma Derivatives
      • 1.2 Blood Plasma Derivatives Segment by Type
        • 1.2.1 Global Blood Plasma Derivatives Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Albumin
        • 1.2.3 Factor VIII
        • 1.2.4 Factor IX
        • 1.2.5 Immunoglobulin
        • 1.2.6 Hyperimmune Globulin
        • 1.2.7 Others
      • 1.3 Blood Plasma Derivatives Segment by Applications
        • 1.3.1 Global Blood Plasma Derivatives Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Other End Users
      • 1.4 Global Blood Plasma Derivatives Overall Market
        • 1.4.1 Global Blood Plasma Derivatives Revenue (2014-2025)
        • 1.4.2 Global Blood Plasma Derivatives Production (2014-2025)
        • 1.4.3 North America Blood Plasma Derivatives Status and Prospect (2014-2025)
        • 1.4.4 Europe Blood Plasma Derivatives Status and Prospect (2014-2025)
        • 1.4.5 China Blood Plasma Derivatives Status and Prospect (2014-2025)
        • 1.4.6 Japan Blood Plasma Derivatives Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Blood Plasma Derivatives Status and Prospect (2014-2025)
        • 1.4.8 India Blood Plasma Derivatives Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Blood Plasma Derivatives
      • 2.3 Manufacturing Process Analysis of Blood Plasma Derivatives
      • 2.4 Industry Chain Structure of Blood Plasma Derivatives

      3 Development and Manufacturing Plants Analysis of Blood Plasma Derivatives

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Blood Plasma Derivatives Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Blood Plasma Derivatives
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Blood Plasma Derivatives Production and Capacity Analysis
      • 4.2 Blood Plasma Derivatives Revenue Analysis
      • 4.3 Blood Plasma Derivatives Price Analysis
      • 4.4 Market Concentration Degree

      5 Blood Plasma Derivatives Regional Market Analysis

      • 5.1 Blood Plasma Derivatives Production by Regions
        • 5.1.1 Global Blood Plasma Derivatives Production by Regions
        • 5.1.2 Global Blood Plasma Derivatives Revenue by Regions
      • 5.2 Blood Plasma Derivatives Consumption by Regions
      • 5.3 North America Blood Plasma Derivatives Market Analysis
        • 5.3.1 North America Blood Plasma Derivatives Production
        • 5.3.2 North America Blood Plasma Derivatives Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Blood Plasma Derivatives Import and Export
      • 5.4 Europe Blood Plasma Derivatives Market Analysis
        • 5.4.1 Europe Blood Plasma Derivatives Production
        • 5.4.2 Europe Blood Plasma Derivatives Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Blood Plasma Derivatives Import and Export
      • 5.5 China Blood Plasma Derivatives Market Analysis
        • 5.5.1 China Blood Plasma Derivatives Production
        • 5.5.2 China Blood Plasma Derivatives Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Blood Plasma Derivatives Import and Export
      • 5.6 Japan Blood Plasma Derivatives Market Analysis
        • 5.6.1 Japan Blood Plasma Derivatives Production
        • 5.6.2 Japan Blood Plasma Derivatives Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Blood Plasma Derivatives Import and Export
      • 5.7 Southeast Asia Blood Plasma Derivatives Market Analysis
        • 5.7.1 Southeast Asia Blood Plasma Derivatives Production
        • 5.7.2 Southeast Asia Blood Plasma Derivatives Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Blood Plasma Derivatives Import and Export
      • 5.8 India Blood Plasma Derivatives Market Analysis
        • 5.8.1 India Blood Plasma Derivatives Production
        • 5.8.2 India Blood Plasma Derivatives Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Blood Plasma Derivatives Import and Export

      6 Blood Plasma Derivatives Segment Market Analysis (by Type)

      • 6.1 Global Blood Plasma Derivatives Production by Type
      • 6.2 Global Blood Plasma Derivatives Revenue by Type
      • 6.3 Blood Plasma Derivatives Price by Type

      7 Blood Plasma Derivatives Segment Market Analysis (by Application)

      • 7.1 Global Blood Plasma Derivatives Consumption by Application
      • 7.2 Global Blood Plasma Derivatives Consumption Market Share by Application (2014-2019)

      8 Blood Plasma Derivatives Major Manufacturers Analysis

      • 8.1 Grifols
        • 8.1.1 Grifols Blood Plasma Derivatives Production Sites and Area Served
        • 8.1.2 Grifols Product Introduction, Application and Specification
        • 8.1.3 Grifols Blood Plasma Derivatives Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 SK Plasma
        • 8.2.1 SK Plasma Blood Plasma Derivatives Production Sites and Area Served
        • 8.2.2 SK Plasma Product Introduction, Application and Specification
        • 8.2.3 SK Plasma Blood Plasma Derivatives Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Fusion Health Care
        • 8.3.1 Fusion Health Care Blood Plasma Derivatives Production Sites and Area Served
        • 8.3.2 Fusion Health Care Product Introduction, Application and Specification
        • 8.3.3 Fusion Health Care Blood Plasma Derivatives Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Biotest AG
        • 8.4.1 Biotest AG Blood Plasma Derivatives Production Sites and Area Served
        • 8.4.2 Biotest AG Product Introduction, Application and Specification
        • 8.4.3 Biotest AG Blood Plasma Derivatives Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Green Cross Corporation
        • 8.5.1 Green Cross Corporation Blood Plasma Derivatives Production Sites and Area Served
        • 8.5.2 Green Cross Corporation Product Introduction, Application and Specification
        • 8.5.3 Green Cross Corporation Blood Plasma Derivatives Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Baxter International
        • 8.6.1 Baxter International Blood Plasma Derivatives Production Sites and Area Served
        • 8.6.2 Baxter International Product Introduction, Application and Specification
        • 8.6.3 Baxter International Blood Plasma Derivatives Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 LFB
        • 8.7.1 LFB Blood Plasma Derivatives Production Sites and Area Served
        • 8.7.2 LFB Product Introduction, Application and Specification
        • 8.7.3 LFB Blood Plasma Derivatives Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Octapharma AG
        • 8.8.1 Octapharma AG Blood Plasma Derivatives Production Sites and Area Served
        • 8.8.2 Octapharma AG Product Introduction, Application and Specification
        • 8.8.3 Octapharma AG Blood Plasma Derivatives Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 CSL Limited
        • 8.9.1 CSL Limited Blood Plasma Derivatives Production Sites and Area Served
        • 8.9.2 CSL Limited Product Introduction, Application and Specification
        • 8.9.3 CSL Limited Blood Plasma Derivatives Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Shire Plc.
        • 8.10.1 Shire Plc. Blood Plasma Derivatives Production Sites and Area Served
        • 8.10.2 Shire Plc. Product Introduction, Application and Specification
        • 8.10.3 Shire Plc. Blood Plasma Derivatives Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 China Biologic Products
      • 8.12 Kedrion Biopharma
      • 8.13 BDI Pharma
      • 8.14 Bayer AG
      • 8.15 Hualan Biological Engineering

      9 Development Trend of Analysis of Blood Plasma Derivatives Market

      • 9.1 Global Blood Plasma Derivatives Market Trend Analysis
        • 9.1.1 Global Blood Plasma Derivatives Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Blood Plasma Derivatives Regional Market Trend
        • 9.2.1 North America Blood Plasma Derivatives Forecast 2019-2025
        • 9.2.2 Europe Blood Plasma Derivatives Forecast 2019-2025
        • 9.2.3 China Blood Plasma Derivatives Forecast 2019-2025
        • 9.2.4 Japan Blood Plasma Derivatives Forecast 2019-2025
        • 9.2.5 Southeast Asia Blood Plasma Derivatives Forecast 2019-2025
        • 9.2.6 India Blood Plasma Derivatives Forecast 2019-2025
      • 9.3 Blood Plasma Derivatives Market Trend (Product Type)
      • 9.4 Blood Plasma Derivatives Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Blood Plasma Derivatives Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
        The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.

        The global Blood Plasma Derivatives market was valued at 24800 million US$ in 2018 and will reach 52000 million US$ by the end of 2025, growing at a CAGR of 9.7% during 2019-2025.
        This report focuses on Blood Plasma Derivatives volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Plasma Derivatives market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Blood Plasma Derivatives in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Blood Plasma Derivatives manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Grifols
        SK Plasma
        Fusion Health Care
        Biotest AG
        Green Cross Corporation
        Baxter International
        LFB
        Octapharma AG
        CSL Limited
        Shire Plc.
        China Biologic Products
        Kedrion Biopharma
        BDI Pharma
        Bayer AG
        Hualan Biological Engineering

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Albumin
        Factor VIII
        Factor IX
        Immunoglobulin
        Hyperimmune Globulin
        Others

        Segment by Application
        Hospitals
        Clinics
        Other End Users

        Buy now